These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10158766)

  • 1. Incorporating quality of life changes into economic evaluations of health care: an overview.
    Blumenschein K; Johannesson M
    Health Policy; 1996 May; 36(2):155-66. PubMed ID: 10158766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-utility analysis from a societal perspective.
    Johannesson M; O'Conor RM
    Health Policy; 1997 Mar; 39(3):241-53. PubMed ID: 10165464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and health economics: where is the link?
    Jönsson B
    Scand J Gastroenterol Suppl; 1996; 221():33-6. PubMed ID: 9110396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Corrective Approach: Policy Implications of Recent Developments in QALY Measurement Based on Prospect Theory.
    Lipman SA; Brouwer WBF; Attema AE
    Value Health; 2019 Jul; 22(7):816-821. PubMed ID: 31277829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating societal concerns for fairness in numerical valuations of health programmes.
    Nord E; Pinto JL; Richardson J; Menzel P; Ubel P
    Health Econ; 1999 Feb; 8(1):25-39. PubMed ID: 10082141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost-utility analyses.
    Rankin J; Rowen D; Howe A; Cleland JGF; Whitty JA
    Heart Fail Rev; 2019 Jul; 24(4):549-563. PubMed ID: 30903357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A welfare economic approach to measure outcomes in stuttering: comparing willingness to pay and quality adjusted life years.
    Franic DM; Bothe AK; Bramlett RE
    J Fluency Disord; 2012 Dec; 37(4):300-13. PubMed ID: 23218213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness-to-pay (WTP): the new-old kid on the economic evaluation block.
    Gafni A
    Can J Nurs Res; 2001 Jun; 33(1):59-64. PubMed ID: 11928155
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A utility-theoretic model for QALYs and willingness to pay.
    Klose T
    Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to pay in the context of an economic evaluation of healthcare programs: theory and practice.
    Gafni A
    Am J Manag Care; 1997 May; 3 Suppl():S21-32. PubMed ID: 10180338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of condition specific outcome measures in economic appraisal.
    Brazier J; Dixon S
    Health Econ; 1995; 4(4):255-64. PubMed ID: 8528428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health outcome measures used in cost-effectiveness studies: a review of original articles published between 1986 and 1996.
    Anell A; Norinder A
    Health Policy; 2000 Mar; 51(2):87-99. PubMed ID: 10699677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do ordering effects matter in willingness-to-pay studies of health care?
    Stewart JM; O'Shea E; Donaldson C; Shackley P
    J Health Econ; 2002 Jul; 21(4):585-99. PubMed ID: 12146592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capabilities as menus: a non-welfarist basis for QALY evaluation.
    Bleichrodt H; Quiggin J
    J Health Econ; 2013 Jan; 32(1):128-37. PubMed ID: 23202258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes.
    Donaldson C; Birch S; Gafni A
    Health Econ; 2002 Jan; 11(1):55-70. PubMed ID: 11788982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where are the economic guidelines coming from?
    McGuire A; Morris S; Raikou M
    Int J Technol Assess Health Care; 2000; 16(4):976-86. PubMed ID: 11155846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating a constant WTP for a QALY-a mission impossible?
    Sund B; Svensson M
    Eur J Health Econ; 2018 Jul; 19(6):871-880. PubMed ID: 28932914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring the Benefits of Healthcare: DALYs and QALYs - Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions.
    Augustovski F; Colantonio LD; Galante J; Bardach A; Caporale JE; Zárate V; Chuang LH; Pichon-Riviere A; Kind P
    Int J Health Policy Manag; 2018 Feb; 7(2):120-136. PubMed ID: 29524936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.